Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
SBI Healthcare Opp Fund-Reg(IDCW)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.12.73222800000469.7280
Domestic EquitiesDivi's Laboratories Ltd.7.3879412222272.5612
Domestic EquitiesMax Healthcare Institute Ltd.6.40482100000236.2920
Domestic EquitiesCipla Ltd.4.76741200000175.8840
Domestic EquitiesLupin Ltd.4.4574840000164.4468
Domestic EquitiesMankind Pharma Ltd.3.7457560000138.1912
Domestic EquitiesKrishna Institute of Medical Sciences Ltd.3.33851800000123.1650
Domestic EquitiesFortis Healthcare Ltd.3.21631680000118.6584
Domestic EquitiesAmi Organics Ltd.3.18841000000117.6300
Domestic EquitiesAster DM Healthcare Ltd.3.18362100000117.4530
Domestic EquitiesJupiter Life Line Hospitals Ltd.3.1763800000117.1840
Domestic EquitiesPolymedicure Ltd.3.1012506557114.4110
Domestic EquitiesAbbott India Ltd.2.971836000109.6380
Domestic EquitiesAether Industries Ltd.2.82771400000104.3210
Domestic EquitiesAlkem Laboratories Ltd.2.7640200000101.9700
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.581630000095.2410
Domestic EquitiesAurobindo Pharma Ltd.2.488980000091.8240
Domestic EquitiesLaurus Labs Ltd.2.4785150000091.4400
Domestic EquitiesRainbow Children's Medicare Ltd.2.433064000089.7600
Domestic EquitiesGland Pharma Ltd.2.325254000085.7844
Domestic EquitiesConcord Biotech Ltd.1.895840000069.9400
Domestic EquitiesBiocon Ltd.1.8207200000067.1700
Domestic EquitiesVijaya Diagnostic Centre Ltd.1.555360000057.3780
Domestic EquitiesCohance Lifesciences Ltd.1.533554000056.5758
Domestic EquitiesPfizer Ltd.1.521510000056.1330
Domestic EquitiesAkums Drugs & Pharmaceuticals Ltd.1.239080000045.7120
Domestic EquitiesSanofi Consumer Healthcare India Ltd.1.07117500039.5145
Domestic EquitiesGufic Biosciences Ltd.1.0598100000039.1000
Total 91.2672 3367.1063
Cash & Cash Equivalents and Net AssetsTREPS3.9906 147.2256
Cash & Cash Equivalents and Net AssetsNet Receivable / Payable-0.1518 -5.5999
Total 3.8388 141.6257
Treasury Bills182 DAY T-BILL 05.06.250.08133000002.9981
Total 0.0813 2.9981
Overseas EquitiesLonza Group4.8127300000177.5545
Total 4.8127 177.5545
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.